ESR1 and neoplasm: In triple-negative breast cancer (TNBC), a highly aggressive subtype lacking estrogen receptor (ER), progesterone receptor (PR), and HER2 expression, Grp94 facilitates tumor progression by activating the Wnt/β-catenin pathway, which promotes brain metastasis in TNBC [155].